Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Merck
Colorcon
AstraZeneca
Boehringer Ingelheim
McKinsey
McKesson

Last Updated: October 17, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR LIVALO

See Plans and Pricing

« Back to Dashboard

Clinical Trials for Livalo

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00344370 Follow-On Study of Pitavastatin Versus Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia Completed Kowa Research Europe Phase 3 2006-08-01 This is a sixteen-week double-blind active-controlled follow-on and 28-week single-blind extension study for patients who participated in study NK-104-305.
NCT00846118 Differential Intervention Trial by Standard Therapy Versus Pitavastatin in Patients With Chronic Hemodialysis (DIALYSIS) Unknown status Chieko Hamada N/A 2009-02-01 The purpose of this study is to verify whether pitavastatin prevents from cardiovascular events and improves the mortality in chronic hemodialysis patients with hypercholesteremia.
NCT00889226 Efficacy and Safety Study of Pitavastatin Compared to atoRvastatin in Type 2 dIabeTes Mellitus With Hypercholesterolemia Completed JW Pharmaceutical Phase 4 2008-04-01 A randomized, open label, dose titration study to evaluate the efficacy and safety of Pitavastatin compared to atorvastatin in Type 2 Diabetes Mellitus with hypercholesterolemia
NCT01057433 Drug-Drug Interaction of Lopinavir/Ritonavir on Pitavastatin Completed Kowa Research Institute, Inc. Phase 4 2010-01-01 This is a Phase 4, single center, open label, fixed-sequence, 2-way drug-drug interaction study.
NCT01166633 Efficacy and Safety Study of Pitavastatin Versus Atorvastatin to Treat Hypercholesterolemia Completed JW Pharmaceutical Phase 4 2009-06-01 Statin is an effective drug to treat hyperlipidemia (hypercholesterolemia), and it rarely leads to hepatic damage to the patients with hepatic disorder. For these patients, intensive monitoring is required.
NCT01256476 Prevail-Us: A Study Of Pitavastatin 4 mg Vs. Pravastatin 40 mg In Patients With Primary Hyperlipidemia Or Mixed Dyslipidemia Completed Kowa Research Institute, Inc. Phase 4 2010-10-01 Randomized, double-blind, double-dummy, 12-week, active-controlled study of pitavastatin 4 mg daily(QD) vs. pravastatin 40 mg daily(QD) in subjects with primary hyperlipidemia or mixed dyslipidemia.
NCT01301066 A 12-Week Study Comparing Pitavastatin 4 mg vs. Pravastatin 40 mg in HIV-Infected Subjects Completed Eli Lilly and Company Phase 4 2010-12-01 A 12-Week, Randomized, Double-Blind, Active-Controlled, Parallel-Group Study.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Livalo

Condition Name

Condition Name for Livalo
Intervention Trials
Dyslipidemia 6
Hyperlipidemia 6
Hypertension 3
HIV 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Livalo
Intervention Trials
Hyperlipidemias 8
Dyslipidemias 7
Diabetes Mellitus, Type 2 2
Diabetes Mellitus 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Livalo

Trials by Country

Trials by Country for Livalo
Location Trials
United States 91
Korea, Republic of 4
Taiwan 1
Germany 1
Poland 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Livalo
Location Trials
Texas 6
New York 5
North Carolina 4
Florida 4
California 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Livalo

Clinical Trial Phase

Clinical Trial Phase for Livalo
Clinical Trial Phase Trials
Phase 4 10
Phase 3 4
Phase 1 3
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Livalo
Clinical Trial Phase Trials
Completed 10
Unknown status 5
Terminated 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Livalo

Sponsor Name

Sponsor Name for Livalo
Sponsor Trials
Kowa Research Institute, Inc. 6
JW Pharmaceutical 6
Kowa Pharmaceuticals America, Inc. 2
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Livalo
Sponsor Trials
Other 29
Industry 17
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKesson
Dow
Merck
Boehringer Ingelheim
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.